Eucommia granules of the treatment of primary osteoporosis clinical observation of low back pain.docVIP

 PAGE \* MERGEFORMAT 10 Eucommia granules of the treatment of primary osteoporosis clinical observation of low back pain Of: Zhang XD, James Tsai, Jian-Hua Tang, Jia Shenghong, Xing-Guo Zhang, Ge Wenjie [Abstract] Objective To observe Eucommia granules of primary osteoporosis prevention and treatment of low back pain patients with the clinical efficacy and changes in biochemical indexes and bone mineral density. Methods Eucommia granules treatment of primary osteoporosis in patients with low back pain 36 cases, 32 cases over the same period alpha calciferol treatment of choice to do the positive control group observed 2 months after treatment of 1,3,6 relief of pain (VAS score), treatment of 6 months testing and biochemical indicators of bone metabolism and bone mineral density . Results 2 groups before and after treatment, VAS score decreased (P lt;0.01), serum osteocalcin, serum alkaline phosphatase, bone alkaline phosphatase were significantly higher (P lt;0.01), urinary calcium / creatinine, urinary hydroxyproline / creatinine decreased significantly (P lt;0.01), bone mineral density increased (P lt;0.05), 2 were no significant differences between the groups. Conclusion Eucommia granules of primary osteoporosis prevention and treatment of low back pain plays a significant role. [Keywords:] Eucommia granules, osteoporosis, bone mineral density, bone pain Abstract: Objective To observe the clinical efficacy of Eucommia granule in treating low back pain from primary osteoporosis and the changes of biochemical indicators and bone density. Methods Thirty-six patients of low back pain were treated with Eucommia granule, and 32 cases with Alpha alcohol ossification. The changes of the pain (VAS score) at 1st, 3rd, and 6th month, blood and urine biochemical indicators and bone density at 6th month were observed before and after treatment. Results After treatment, VAS score dropped (P lt;0.01) , S-BGP, S-ALP and S-BALP significantly increased (P lt;0.01)